News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,965 Results
Type
Article (16030)
Company Profile (311)
Press Release (283617)
Multimedia
Podcasts (79)
Webinars (11)
Section
Business (83432)
Career Advice (400)
Deals (14031)
Drug Delivery (43)
Drug Development (51144)
Employer Resources (45)
FDA (6080)
Job Trends (5824)
News (150427)
Policy (10476)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1049)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (23138)
ALS (125)
Alzheimer's disease (1066)
Antibody-drug conjugate (ADC) (241)
Approvals (6279)
Artificial intelligence (288)
Autoimmune disease (112)
Automation (14)
Bankruptcy (106)
Best Places to Work (5209)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (237)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (350)
Cancer (3170)
Cardiovascular disease (240)
Career advice (348)
Career pathing (13)
CAR-T (217)
CDC (5)
Cell therapy (568)
Cervical cancer (14)
Clinical research (44052)
Collaboration (1188)
Company closure (2)
Compensation (611)
Complete response letters (39)
COVID-19 (1139)
CRISPR (88)
C-suite (567)
Cystic fibrosis (113)
Data (4399)
Denatured (15)
Depression (92)
Diabetes (264)
Diagnostics (1638)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (194)
Drug pricing (52)
Drug shortages (5)
Duchenne muscular dystrophy (217)
Earnings (32431)
Editorial (27)
Employer branding (4)
Employer resources (42)
Events (53539)
Executive appointments (652)
FDA (7894)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1020)
Gene editing (186)
Generative AI (23)
Gene therapy (496)
GLP-1 (526)
Government (1239)
Grass and pollen (3)
Guidances (181)
Healthcare (7026)
HIV (19)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (40)
Indications (66)
Infectious disease (1246)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (42)
Intellectual property (166)
Interviews (74)
IPO (7592)
IRA (12)
Job creations (925)
Job search strategy (272)
JPM (43)
Kidney cancer (9)
Labor market (25)
Layoffs (247)
Leadership (13)
Legal (1477)
Liver cancer (41)
Longevity (11)
Lung cancer (429)
Lymphoma (256)
Machine learning (26)
Management (10)
Manufacturing (404)
MASH (130)
Medical device (3137)
Medtech (3147)
Mergers & acquisitions (7088)
Metabolic disorders (749)
Multiple sclerosis (115)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (2014)
Neurotech (1)
NextGen: Class of 2026 (2290)
Non-profit (1136)
Now hiring (30)
Obesity (341)
Opinion (142)
Ovarian cancer (131)
Pain (104)
Pancreatic cancer (161)
Parkinson's disease (240)
Partnered (15)
Patents (303)
Patient recruitment (330)
Peanut (43)
People (27776)
Pharmaceutical (46)
Pharmacy benefit managers (8)
Phase 1 (15550)
Phase 2 (20431)
Phase 3 (13003)
Pipeline (3331)
Policy (95)
Postmarket research (867)
Preclinical (6579)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (657)
Real estate (1623)
Recruiting (19)
Regulatory (10199)
Reports (19)
Research institute (1058)
Resumes & cover letters (65)
Rett syndrome (24)
RNA editing (21)
RSV (18)
Schizophrenia (127)
Series A (190)
Series B (137)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (21)
Startups (2097)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (20)
The Weekly (63)
Vaccines (338)
Venture capital (70)
Weight loss (182)
Women's health (26)
Worklife (4)
Date
Today (27)
Last 7 days (350)
Last 30 days (1177)
Last 365 days (18325)
2026 (1724)
2025 (18614)
2024 (21187)
2023 (23188)
2022 (28637)
2021 (30693)
2020 (26139)
2019 (17955)
2018 (12964)
2017 (14504)
2016 (12571)
2015 (15094)
2014 (10919)
2013 (7949)
2012 (8123)
2011 (8169)
2010 (7765)
Location
Africa (197)
Alabama (66)
Alaska (4)
Arizona (78)
Arkansas (5)
Asia (18842)
Australia (3221)
California (7305)
Canada (1868)
China (780)
Colorado (252)
Connecticut (264)
Delaware (236)
Europe (40879)
Florida (916)
Georgia (223)
Hawaii (2)
Idaho (18)
Illinois (409)
India (36)
Indiana (273)
Iowa (9)
Japan (234)
Kansas (82)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (764)
Massachusetts (5743)
Michigan (112)
Minnesota (279)
Mississippi (3)
Missouri (41)
Montana (16)
Nebraska (5)
Nevada (34)
New Hampshire (21)
New Jersey (1660)
New Mexico (14)
New York (1799)
North Carolina (849)
North Dakota (7)
Northern California (3566)
Ohio (200)
Oklahoma (12)
Oregon (26)
Pennsylvania (1294)
Puerto Rico (10)
Rhode Island (27)
South America (260)
South Carolina (12)
Southern California (2890)
Tennessee (43)
Texas (935)
United States (24130)
Utah (100)
Virginia (138)
Washington D.C. (39)
Washington State (606)
West Virginia (1)
Wisconsin (47)
299,965 Results for "solve therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solve Therapeutics Raises $120 Million to Develop Best-in-Class ADCs for Solid Tumors
November 18, 2025
·
3 min read
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just as regulatory and government policies spark momentum and frustration.
January 28, 2026
·
4 min read
·
Heather McKenzie
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
November 6, 2025
·
6 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
June 9, 2025
·
3 min read
Deals
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out
Solve Therapeutics, Inc. announces the acquisition of Cereius, Inc.
June 22, 2023
·
4 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
Press Releases
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit
February 4, 2026
·
5 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
1 of 29,997
Next
